233 related articles for article (PubMed ID: 22939114)
1. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.
DeCroos FC; Toth CA; Stinnett SS; Heydary CS; Burns R; Jaffe GJ;
Ophthalmology; 2012 Dec; 119(12):2549-57. PubMed ID: 22939114
[TBL] [Abstract][Full Text] [Related]
2. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.
Folgar FA; Jaffe GJ; Ying GS; Maguire MG; Toth CA;
Ophthalmology; 2014 Oct; 121(10):1956-65. PubMed ID: 24835760
[TBL] [Abstract][Full Text] [Related]
3. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Jaffe GJ; Martin DF; Toth CA; Daniel E; Maguire MG; Ying GS; Grunwald JE; Huang J;
Ophthalmology; 2013 Sep; 120(9):1860-70. PubMed ID: 23642377
[TBL] [Abstract][Full Text] [Related]
4. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
5. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM
Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838
[TBL] [Abstract][Full Text] [Related]
6. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.
Keane PA; Patel PJ; Ouyang Y; Chen FK; Ikeji F; Walsh AC; Tufail A; Sadda SR
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5431-7. PubMed ID: 20554607
[TBL] [Abstract][Full Text] [Related]
7. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
[TBL] [Abstract][Full Text] [Related]
8. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.
Kashani AH; Keane PA; Dustin L; Walsh AC; Sadda SR
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3366-73. PubMed ID: 19168893
[TBL] [Abstract][Full Text] [Related]
9. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT).
Lee JY; Folgar FA; Maguire MG; Ying GS; Toth CA; Martin DF; Jaffe GJ;
Ophthalmology; 2014 Dec; 121(12):2423-31. PubMed ID: 25064723
[TBL] [Abstract][Full Text] [Related]
10. Risk of scar in the comparison of age-related macular degeneration treatments trials.
Daniel E; Toth CA; Grunwald JE; Jaffe GJ; Martin DF; Fine SL; Huang J; Ying GS; Hagstrom SA; Winter K; Maguire MG;
Ophthalmology; 2014 Mar; 121(3):656-66. PubMed ID: 24314839
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography reader agreement in neovascular age-related macular degeneration.
Zhang N; Hoffmeyer GC; Young ES; Burns RE; Winter KP; Stinnett SS; Toth CA; Jaffe GJ
Am J Ophthalmol; 2007 Jul; 144(1):37-44. PubMed ID: 17509508
[TBL] [Abstract][Full Text] [Related]
12. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Ying GS; Huang J; Maguire MG; Jaffe GJ; Grunwald JE; Toth C; Daniel E; Klein M; Pieramici D; Wells J; Martin DF;
Ophthalmology; 2013 Jan; 120(1):122-9. PubMed ID: 23047002
[TBL] [Abstract][Full Text] [Related]
13. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab.
Sayanagi K; Sharma S; Yamamoto T; Kaiser PK
Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732
[TBL] [Abstract][Full Text] [Related]
14. Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Shah N; Maguire MG; Martin DF; Shaffer J; Ying GS; Grunwald JE; Toth CA; Jaffe GJ; Daniel E;
Ophthalmology; 2016 Apr; 123(4):858-64. PubMed ID: 26778329
[TBL] [Abstract][Full Text] [Related]
15. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
[TBL] [Abstract][Full Text] [Related]
16. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Willoughby AS; Ying GS; Toth CA; Maguire MG; Burns RE; Grunwald JE; Daniel E; Jaffe GJ;
Ophthalmology; 2015 Sep; 122(9):1846-53.e5. PubMed ID: 26143666
[TBL] [Abstract][Full Text] [Related]
17. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Grunwald JE; Daniel E; Ying GS; Pistilli M; Maguire MG; Alexander J; Whittock-Martin R; Parker CR; Sepielli K; Blodi BA; Martin DF;
Ophthalmology; 2012 Aug; 119(8):1634-41. PubMed ID: 22512984
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration.
Joeres S; Tsong JW; Updike PG; Collins AT; Dustin L; Walsh AC; Romano PW; Sadda SR
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4300-7. PubMed ID: 17724220
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
